NCT02387918

Brief Summary

Tonsillectomy is one of the most frequently performed surgical procedures in children. It remains associated with a high morbidity related to postoperative vomiting (POV), pain, risk of bleeding, and dehydration due to impaired oral intake. Current medications for POV have limited efficacy and may even be associated with potential side-effects. Non-pharmacological techniques such as acupuncture has been investigated as alternatives to antiemetics and as additional treatment modalities for POV.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Feb 2015

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2015

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

February 27, 2015

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 13, 2015

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
Last Updated

January 22, 2016

Status Verified

January 1, 2016

Enrollment Period

8 months

First QC Date

February 27, 2015

Last Update Submit

January 20, 2016

Conditions

Keywords

Tonsillectomypostoperative vomiting (POV)DexamethasoneAcupuncture

Outcome Measures

Primary Outcomes (1)

  • Incidence of POV after tonsillectomy with or without adenoidectomy

    by 3 point ordinal scale

    24 hours postoperatively

Study Arms (2)

Dexamethasone

ACTIVE COMPARATOR

Patients will receive Intravenous dexamethasone 0.15 mg/kg immediately after induction of anesthesia.

Drug: Dexamethasone

Acupuncture

ACTIVE COMPARATOR

Acupuncture at point Neiguan (Pericardium-6) bilaterally and at point CV13 (Shang Wen) with acupuncture needles (0.25x25 mm) to a depth of approximately 7 mm will be performed on the children immediately after induction of anaesthesia and removed after 20 minutes

Device: Acupuncture

Interventions

Patients will receive Intravenous dexamethasone 0.15 mg/kg immediately after induction of anesthesia.

Dexamethasone

Acupuncture treatment (just after induction of anaesthesia and for approximately 20 minutes)

Acupuncture

Eligibility Criteria

Age2 Years - 8 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • children aged 2-8 y.
  • children ASA 1-2
  • tonsillectomy with or without adenoidectomy

You may not qualify if:

  • American Society of Anesthesiologists grade greater than or equal to III (patient with severe systemic disease)
  • intravenous induction
  • contraindication to steroids
  • Rash or local infection over an acupuncture point
  • administration of steroids in the 24 hours before the surgery
  • Use of medication with antiemetic effect within the 24 hours before surgery
  • Gastric or intestinal diseases
  • refusal of parents

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine Assuit University

Egypt, Assuit, 71111, Egypt

Location

MeSH Terms

Conditions

VomitingPostoperative Nausea and Vomiting

Interventions

DexamethasoneAcupuncture Therapy

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesNausea

Intervention Hierarchy (Ancestors)

PregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, FluorinatedComplementary TherapiesTherapeutics

Study Officials

  • Seham Ibrahim, Lecturer

    health,Higher education

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 27, 2015

First Posted

March 13, 2015

Study Start

February 1, 2015

Primary Completion

October 1, 2015

Study Completion

October 1, 2015

Last Updated

January 22, 2016

Record last verified: 2016-01

Locations